H.I.G. BioHealth Partners

H.I.G. BioHealth Partners is the dedicated life-science investment affiliate of H.I.G. Capital, specializing in healthcare investments across various sectors and stages. The firm primarily focuses on companies developing therapeutic drugs, medical devices, and diagnostics aimed at addressing significant unmet medical needs. With approximately $400 million in committed capital, H.I.G. BioHealth Partners invests between $5 million and $40 million per company over the life of an investment.

The firm's investment strategy encompasses a broad spectrum of healthcare opportunities, including therapeutic drugs, medical devices, and diagnostics. H.I.G. BioHealth Partners engages in investments across multiple stages, from early-stage ventures to growth and late-stage companies, as well as pre-IPO and buyout opportunities. Geographically, the firm has a diverse focus, investing in the United States, Europe, Asia, and Latin America.

H.I.G. BioHealth Partners has a track record of supporting innovative healthcare companies. Notable investments include Click Therapeutics, a leader in digital therapeutics for smoking cessation and major depressive disorder, and VertiFlex, a developer of minimally invasive solutions for lumbar spinal stenosis. The firm's approach combines operational expertise with a flexible investment strategy to drive value creation in its portfolio companies.